Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway

Non-small-cell lung cancer (NSCLC) is a dominating type of lung cancer with high morbidity and mortality. Midazolam has been reported to promote cell apoptosis in NSCLC, but the molecular mechanism of midazolam remains to be further explored. In the current work, cell viability, proliferation, migra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiangchao, Han, Zhe, Li, Zhengjun, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251164/
https://www.ncbi.nlm.nih.gov/pubmed/37305523
http://dx.doi.org/10.1515/med-2023-0730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251164/
https://www.ncbi.nlm.nih.gov/pubmed/37305523
http://dx.doi.org/10.1515/med-2023-0730

Ejemplares similares